Researchers performed untargeted ultra-high performance liquid chromatography coupled to high-resolution mass spectrometry-based polar metabolomics and lipidomics to non-transformed and transformed colon cell lines as well as tissue samples from ten colorectal cancer patients.
[Scientific Reports]